2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p [q] r s t u v w x y z

Quailty of life and Parkinson’s disease: Philippine translation and validation of the Parkinson’s disease questionnaire

C. Suratos, G. Saranza, D. Sumalapao, R. Jamora (Manila, Philippines)
Quality of Life and Psychiatric Comorbidities Comparisons in Patients with Functional (Psychogenic) and Organic Movement Disorders

T. Gendre, G. Carle, F. Mesrati, M. Houot, B. Degos, B. Garcin (Créteil, France)
Quality of life in Chinese Parkinson’s disease patients with Subthalamic Deep Brain Stimulation in Hong Kong: A single center prospective study

C. Lau, C. Zhu, D. Chan, K. Ma, A. Chan, J. Yeung, W. Poon, V. Mok (Hong Kong, Hong Kong)
Quality of Life in Parkinson’s Disease: Impact of Depression and Apathy

H. Nagayama (Tokyo, Japan)
Quality of Life in Tic Disorders: An Observational, Mainstream School-Based Population Study over Time

E. Casas-Peña, B. Ouyang, Y. Liu, E. Cubo, K. Kompoliti (Burgos, Spain)
Quantification of the PD Motor Syndrome Using an Inclusive Score (PD9) Derived from Sensor Data with Deep Learning

F. Pfister, J. Goschenhofer, T. Um, D. Pichler, K. Abedinpour, D. Kulic, B. Bischl, A. Ceballos-Baumann, U. Fietzek (Munich, Germany)
Quantifying the Reproducibility of an In Vivo Assay: Examination of Historical Amantadine Effects in the macaque Model of L-DOPA-Induced Dyskinesia

E. Pioli, P. Stanley, W. Ko, Q. Li, R. Kozak, P. Popiolek, E. Bezard (Manchester, United Kingdom)
Quantitative analysis of DaT uptake and neuromelanin MR contrast in patients with Parkinson’s disease and healthy controls

D. Ben Bashat, M. Artzi, A. Mirelman, T. Thaler, A. Orr Urterger, M. Weisz, E. Even-Sapir, K. Evans, R. Hutchison, J. Cedarbaum, H. Lerman Shacham (Tel Aviv, Israel)
Quantitative Assessment of Appendicular Bradykinesia in Parkinson’s Disease using Wearable Sensors

A. Dowling, M. Brys, J. Paskavitz, V. Auclair, D. McLaren, R. Postuma, B. Bedell, M. Cedarbaum (Cambridge, MA, USA)
Quantitative assessment of the effectiveness of adaptive Deep Brain Stimulation in Parkinson’s disease

D. Piña-Fuentes, M. Tijssen, M. Oterdoom, S. Little, J. van Zijl, T. van Laar, P. Brown, M. van Dijk, M. Beudel (Groningen, Netherlands)
Quantitative assessment of the hand motor symptoms in Parkinson’s disease based on a custom wearable device: A Proof-of-Principle Study

Q. Ye, Z. Lin, H. Dai, Y. Xiong, G. Cai (Jinjiang, China)
Quantitative characterisation of tremor in functional and organic tremor patients

Z. Dominguez-Vega, G. Kramer, J. Elting, M. de Koning-Tijssen, N. Maurits (Groningen, Netherlands)
Quantitative EEG and medial temporal lobe atrophy in early Parkinson’s disease with behavioral and psychological symptoms

J.Y. Ahn, H.T. Kim (Seoul, Republic of Korea)
Quantitative Keyboard Tapping Measurement Correlates with Electrophysiological Changes in STN LFPs of PD Patients Treated with L-dopa Better Than UPDRS Subscores

M. Ozturk, A. Abosch, D. Francis, J. Wu, N. Ince (Houston, TX, USA)
Quantitative Midbrain Measurement in Diagnosing Variants of Progressive Supranuclear Palsy

H. Wang, YW. Zhang, J. Yuan, D. Xu, H. You, ML. Li, F. Feng (Beijing, China)
Quantitative mobility metrics from a body-fixed sensor predict incident parkinsonism in older adults

R. von Coelln, R. Dawe, J. Shulman, L. Yu, S. Leurgans, J. Hausdorff, L. Shulman, D. Bennett, A. Buchman (Baltimore, MD, USA)
Quantitative oculomotor assessment and non-motor biomarkers in late-onset GM2 gangliosidosis

C. Stephen, D. Balkwill, P. James, K. Sassower, J. Schmahmann, R. Lewis, F. Eichler (Boston, MA, USA)

Jump to: View All • a b c d e f g h i j k l m n o p [q] r s t u v w x y z